ImmunoGen

IMGN

IMGN
ImmunoGen Stock Quote
$3.21 -$0.18 -5.3%
BATS BZX Real Time Price as of September 17, 2019, 4:00 p.m. EDT View Interactive IMGN Charts

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

News & Analysis: ImmunoGen

The Fool has written over 200 articles on ImmunoGen.

All

Market Moves

Earnings




Why ImmunoGen Shares Are Crashing Today

Disappointing news from the FDA means that the biotech company is further from potentially winning approval for its lead drug candidate.








Interactive Chart